TEOSSTreatment of Early Onset Schizophrenia Spectrum Disorders (study)
TEOSSTactical Emitter Operational Support System
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Antipsychotics in children with schizophrenia: TEOSS study adds to debate about efficacy and tolerability
The 5-year National Institute of Mental Health-funded Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) trial began with an ambitious goal: to compare the efficacy and safety of 1 typical and 2 atypical antipsychotics in children age 8 to 19 with schizophrenia.
Frazier discusses the unexpected findings of the TEOSS trial with CURRENT PSYCHIATRY Section Editor Robert A.
KOWATCH: The TEOSS trial found no significant differences in efficacy between molindone and the atypical antipsychotics (olanzapine and risperidone) included in the study.
KOWATCH: Have you changed the way you prescribe antipsychotics as a result of the TEOSS study?
KOWATCH: Do you think the TEOSS study had adequate power to demonstrate differences among molindone, olanzapine, and risperidone?
KOWATCH: The TEOSS study found 50% or lower response rates across 8 weeks of antipsychotic treatment.